Takeda Pharmaceutical Co. Ltd. has what may be a lean year ahead as it looks to cut costs in 2024 and eyes a return to growth in 2025.
The Osaka, Japan-based drug maker announced its fiscal year 2023 results on 9 May, reporting a 5.9% increase in revenue...








